共 43 条
[1]
Siegel RL(2020)Cancer statistics, 2020 CA Cancer J Clin 70 7-30
[2]
Miller KD(2016)2016 US lymphoid malignancy statistics by World Health Organization subtypes CA Cancer J Clin 66 443-459
[3]
Jemal A(2012)Small lymphocytic lymphoma and chronic lymphocytic leukemia: are they the same disease? Cancer J 18 396-403
[4]
Teras LR(2011)State of the art treatment of chronic lymphocytic leukaemia Blood Rev 25 1-9
[5]
Santos FP(2016)Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial Blood 127 208-215
[6]
O'Brien S(2020)Treatment of chronic lymphocytic leukemia N Engl J Med 383 460-473
[7]
Hallek M(2015)Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia N Engl J Med 373 2425-2437
[8]
Pflug N(2008)Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines Blood 111 5446-5456
[9]
Fischer K(2014)Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia N Engl J Med 371 213-223
[10]
Burger JA(2016)Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study Lancet Oncol 17 1409-1418